Dynamics Special Purpose Corp. (DYNS): Price and Financial Metrics

Dynamics Special Purpose Corp. (DYNS): $7.51

0.49 (-6.13%)

POWR Rating

Component Grades








DYNS Price/Volume Stats

Current price $7.51 52-week high $10.54
Prev. close $8.00 52-week low $7.18
Day low $7.18 Volume 92,100
Day high $8.44 Avg. volume 65,747
50-day MA $9.76 Dividend yield N/A
200-day MA $9.88 Market Cap 178.10M

DYNS Stock Price Chart Interactive Chart >

Dynamics Special Purpose Corp. (DYNS) Company Bio

Dynamics Special Purpose Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2021 and is based in Redwood City, California.

DYNS Latest News Stream

Event/Time News Detail
Loading, please wait...

DYNS Latest Social Stream

Loading social stream, please wait...

View Full DYNS Social Stream

Latest DYNS News From Around the Web

Below are the latest news stories about DYNAMICS SPECIAL PURPOSE CORP that investors may wish to consider to help them evaluate DYNS as an investment opportunity.

Could The Dynamics Special Purpose Corp. (NASDAQ:DYNS) Ownership Structure Tell Us Something Useful?

A look at the shareholders of Dynamics Special Purpose Corp. ( NASDAQ:DYNS ) can tell us which group is most powerful...

Yahoo | March 10, 2022

Senti Bio to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (“Senti Bio”), a leading Gene Circuit company today announced that Tim Lu, MD, PhD, Chief Executive Officer and Co-Founder, will present a corporate overview at the 40th Annual J.P. Morgan Virtual Healthcare Conference on Tuesday, January 11, 2022 at 2:00 p.m. EST. Senti Bio uses its Gene Circuit platform to program cell and gene therapies with potentially enhanced capabilities. Gene Circuits, which are create

Yahoo | January 6, 2022

Peninsula 'gene circuits' company taking blank-check route to go public

Initially targeting cancers, Senti believes cells and genes can be engineered to be triggered like computer circuits to perform specific, unique tasks.

Yahoo | December 20, 2021

Senti Bio and Dynamics Special Purpose Corp. Announce Business Combination Agreement to Create Publicly Listed Company Pioneering Gene Circuit-Engineered Cell and Gene Therapies

- Business combination with Dynamics Special Purpose Corp. (Nasdaq: DYNS) is expected to provide more than $296 million in gross proceeds, over $153 million of which is fully committed in a common stock Private Investment in Public Equity (“PIPE”) financing and from non-redemption agreements - - Over $86 million in non-redemption agreements committed from existing Dynamics investors including funds managed by ARK Investment Management LLC, funds and accounts managed by Counterpoint Global (Morga

Yahoo | December 20, 2021

Former Illumina execs, Grail co-founder raise $21M for biotech startup

Illumina Inc.'s ex-chief technology officer and former colleagues raised $21 million for a startup biotech company that, according to a job posting, is seeking engineers and scientists "with a passion to develop the next generation of technologies for unraveling complexities of biology beyond what is within the realm of possibility today.

Yahoo | December 8, 2021

Read More 'DYNS' Stories Here

DYNS Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year -25.20%
5-year N/A
2023 N/A
2022 0.00%
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!